Sudeep Pharma shares rally 8% after solid listing pop. Should you buy, sell or hold?
[hfe_template id='11223']
[ad_1]
Sudeep Pharma’s debut on Dalal Street turned into a sharp rally on Friday, with the newly listed stock climbing as much as 8.2% on the NSE to Rs 789.8 from its opening price of Rs 730 and rising 6.8% on the BSE to Rs 784 from Rs 733.95, as a 24% listing pop transformed strong pre-IPO demand into immediate gains for investors. Sudeep Pharma made a strong D-Street debut, listing at a premium of nearly 24% on the bourses. The stock opened at Rs 733.95 apiece on the BSE against the issue price of Rs 593, reflecting a 23.76% premium. On the NSE, it debuted at Rs 730 per share, a 23.10% premium. The listing was broadly in line with grey market expectations, with the GMP hovering around 20% just ahead of the debut. Should you buy, sell or hold Sudeep Pharma shares? With the stock racing ahead of its issue price on debut, investor focus has shifted from celebration to calculation and whether the rally has further to run or already discounts much ...